Piramal Enterprises Limited (PEL) is one of India’s large diversified companies, with a presence in Financial Services, Pharmaceuticals and Healthcare Insights & Analytics. PEL’s consolidated revenues were $1.9 Billion in FY2019, with 40% of revenues generated from outside India.
In Financial Services, Piramal Capital & Housing Finance Limited (PCHFL), a wholly owned subsidiary of Piramal Enterprises Limited (the flagship company of Piramal Group), is registered as a housing finance company with the National Housing Bank (NHB) and is engaged in various financial services businesses. It provides wholesale financing to real estate developers and corporate clients, and retail housing loans to individual customers. In real estate, the platform provides financing solutions across the entire capital stack such as structured debt, construction finance, flexi lease rental discounting etc. to developers and housing finance to home buyers. The wholesale business in non-real estate sectors includes separate verticals – Corporate Finance (CFG) and Emerging Corporate Lending (ECL). CFG provides customised funding solutions to companies across sectors such as infrastructure, renewable energy, roads, industrials, auto components etc. while ECL focuses on lending towards Small and Medium Enterprises (SMEs).
PCHFL’s group companies maintain strategic partnerships with leading global pension funds such as CPPIB, APG and Ivanhoe Cambridge.
The division has also launched a distressed asset investing platform with Bain Capital Credit - India - RF that will invest in equity and / or debt in assets across sectors (other than real estate) to drive restructuring with active participation in turnaround. PEL also has long term equity investments worth ~$1 Billion in Shriram Group, a leading financial conglomerate in India.
In Pharma, through an end-to-end manufacturing capabilities across 13 global facilities and a large global distribution network to over 100 countries, PEL sells a portfolio of niche differentiated pharma products and provides an entire pool of integrated pharma services including in the areas of injectable, HPAPIs (High Potency Active Pharmaceutical Ingredients), ADCs (Antibody Drug Conjugates) etc. The Company is also focusing on growing the Consumer Products segment in India.
PEL’s Healthcare Insights & Analytics business is the premier provider of healthcare analytics, data & insight products and services to the world’s leading pharma, biotech and medical technology companies and enables them to take informed business decisions.
HIGHLIGHTS OF THE COMPANY
Employees
Presence in
locations in 18 countries
Revenue CAGR for 31 years
Net Profit CAGR for 31 years
Dividend Payout Ratio1
Annualised shareholder
returns over the last 31 years
Market Capitalisation as on March 31, 2019
Notes: 1. Recommended by the Board
CORE VALUES
Expertise
We strive for a deeper
understanding of our domain.
Innovation
We aspire to do things
creatively.
Entrepreneurship
We are empowered to act
decisively and create value.
Integrity
We are consistent in our
thought, speech and action.
Trusteeship
We protect and enhance the interests of our customers, community, employees, partners and shareholders.
Humility
We aspire to be the best, yet strive to be humble.
Performance
We strive to achieve market leadership in scale and profitability, wherever we compete.
Resilience
We aspire to build businesses
that anticipate, adapt and
endure for generations.
At Piramal Group, our core values of Knowledge, Action, Care and Impact are integral to our guiding philosophy. These values represent our deeply held beliefs and define us at the individual as well as the organisational levels. We encourage a deep understanding of these core values and believe in institutionalising them across the organisation to build a distinctive Piramal culture.
We stay true to our purpose of ‘Doing Well and Doing Good’ by following three basic tenetsServing People
We aim to serve our customers, community, employees, partners and all other stakeholders by putting their needs and well-being first.
Making a Positive Difference
We aim to make a positive difference through our products, services, customer-centric approach and innovation-led research.
Living Our Values
We live by our values in our everyday actions, decisions and conduct, at a personal as well as a professional level.
CORPORATE STRUCTURE
Wholesale Lending
Housing Finance
Alternative Asset Management
Diversified Retail Exposure via Shriram
2019 Capital Employed1 60%
Global Pharma
India Consumer Products
2019 Capital Employed1 23%
Decision Resources Group (DRG)
2019 Capital Employed1 17%
Notes: